Neoadjuvant TP (Cisplatin-Docetaxel) for patients unfit to TPF (Cisplatin-Docetaxel-5FU) in locally advanced head and neck squamous cell cancer (LAHNSCC): an exploratory study on 14 patients | Zendy

AI Assistant Blog Pricing

Neoadjuvant TP (Cisplatin-Docetaxel) for patients unfit to TPF (Cisplatin-Docetaxel-5FU) in locally advanced head and neck squamous cell cancer (LAHNSCC): an exploratory study on 14 patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.